Tag

Merck

Innovation

Merck to Acquire Afferent Pharmaceuticals
DNA

Merck Names Sanat Chattopadhyay President of Merck Manufacturing Division
research lab

Merck and MD Anderson Cancer Center Announce Strategic Immuno-Oncology Research Collaboration
Handshake

Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman
scientist

NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award
lab

Stevens Institute of Technology Receives $251,000 Instrumentation Donation from Merck
prescription drugs

Merck to Acquire Cubist Pharmaceuticals
healthcare vaccine

Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine
prescription drugs

Merck Receives Accelerated Approval of KEYTRUDA® (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy
prescription drugs

FDA Approves Merck’s BELSOMRA® (suvorexant) for the Treatment of Insomnia
F22 fighter jet

July Business Briefs
test tubes

Merck Launches Global Patient Registry Supporting Expanded Commitment to Real-World Outcomes Research in Type 2 Diabetes
Innovation

Merck to Acquire Idenix
pills

June Business Briefs
eye exam

Merck Signs Sale Agreement with Santen for Merck’s Ophthalmology Products
Pharmaceutical

Bayer to Acquire Consumer Care Business of US-based Merck & Co., Inc.